Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?-Reference-Cited by-同舟云学术

Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?

Published:2020-08-28 Issue:11 Volume:222 Page:1772-1775
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Takahashi Saki¹^ORCID,Greenhouse Bryan¹²^ORCID,Rodríguez-Barraquer Isabel¹^ORCID

Affiliation:

1. EPPIcenter Program, Division of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA

2. Chan Zuckerberg Biohub, San Francisco, California, USA

Abstract

Abstract Biased seroprevalence estimates can occur using serological assays optimized with validation sets unrepresentative of disease spectrum in the general population. Correct interpretation of serosurveys for severe acute respiratory syndrome coronavirus 2 requires quantifying variations in sensitivity with disease severity and over time.

Funder

Rhodes Trust

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa523/33832683/jiaa523.pdf

Reference20 articles.

1. Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland;Stringhini;Lancet,2020

2. Serology assays to manage COVID-19.;Krammer,2020

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential for bias in (sero)prevalence estimates when not accounting for test sensitivity and specificity: a systematic review;2024-07-19

2. Estimating geographic variation of infection fatality ratios during epidemics;Infectious Disease Modelling;2024-06

3. Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model;Scientific Reports;2024-04-25

4. Early detection of new pandemic waves. Control chart and a new surveillance index;PLOS ONE;2024-02-12

5. Estimating cutoff values for diagnostic tests to achieve target specificity using extreme value theory;BMC Medical Research Methodology;2024-02-08